Assembly Biosciences (ASMB) Operating Margin (QoQ) (2017 - 2026)

Assembly Biosciences (ASMB) Operating Margin (QoQ) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Assembly Biosciences 431.63 Mn 205.03 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -18,506.00
Dec 31, 2025 14,749.00
Sep 30, 2025 1,437.00
Jun 30, 2025 -970.00
Mar 31, 2025 5,121.00
Dec 31, 2024 331.00
Sep 30, 2024 -1,705.00
Jun 30, 2024 4,245.00
Mar 31, 2024 -1,024.00
Dec 31, 2020 -381,115.00
Sep 30, 2020 -2,832.00
Jun 30, 2020 69,532.00
Mar 31, 2020 -7,689.00
Dec 31, 2019 1,263.00
Sep 30, 2019 2,526.00
Jun 30, 2019 8,976.00
Mar 31, 2019 -2,463.00
Dec 31, 2018 -17,802.00
Sep 30, 2018 31,747.00
Jun 30, 2018 -37,653.00